台股 » 個股 » 旭富 » 籌碼相關 » 券商分點績效

旭富

(4119)
可現股當沖
  • 股價
    90.0
  • 漲跌
    ▼0.4
  • 漲幅
    -0.44%
  • 成交量
    233
  • 產業
    上市 生技醫療類股
  • 353人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
旭富 (4119)籌碼相關-券商分點績效/獲利分析
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

«前一日     2024/04/16 ~ 2024/04/30     後一日»

券商獲利排行 - 2024/04/16 ~ 2024/04/30

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  2.36%118.40118.45757087.987.9090
  2.60%105.10105.14646087.787.7090
  1.02%88.3-22.4110.754994587.887.987.590
  2.36%83479374038887.989.290
  2.70%7132.738.212301887.586.888.690
  1.57%69.7069.75050088.688.6090
  1.59%66.8-10.27737481187.787.98790
  1.06%65.6-9.975.560701088.688.787.890
  3.78%65.6065.62020086.786.7090
  1.77%51.151.100333387.686.888.490
  0.68%4754219795987.987.98890
  1.69%390392626088.588.5090
  2.80%36.8036.81515087.587.5090
  2.90%35.4-0.836.21314187.287.286.490
  2.22%33.3033.3171708888090
  1.93%32.4-0.733.11819188.188.287.590
  3.69%326.125.9710386.886.388.390
  3.59%31.2031.21010086.986.9090
  1.87%29.7128.71518288.388.288.790
  0.67%29.5-2756.53650148888.486.590
  2.78%26.8026.81111087.687.6090
  3.85%26.7026.788086.786.7090
  1.36%26.3-2.628.91422887.887.987.690
  2.56%24.7024.71011087.887.888.190
  2.65%23.22.820.4810287.787.488.990
  3.64%22.1022.177086.886.8090
  2.25%21.7516.7511587.587.288.290
  3.47%215.515.647386.686.187.990
  4.02%20.9020.966086.586.587.890
  1.90%20.1020.11212088.388.3090
  2.54%20.1020.199087.887.8090
  3.50%18.32.31656187.186.889.190
  0.94%17.614.43.22211988.788.489.190
  3.90%16.9016.955086.686.6090
  1.72%16.7-0.917.69112888887.690
  3.17%16.6016.666087.287.2090
  3.70%1601655086.886.8090
  1.82%16016810288888890
  3.62%15.7015.755086.986.9090
  2.54%15.62.912.747287.887.588.990
  2.09%14.70.913.878188.18888.990
  2.33%14.35.68.737487.687.188.590
  0.67%13.615.5-1.9-1222387.787.388.190
  3.69%12.8012.844086.886.8090
  1.40%12.43.88.5410588.588.389.190
  1.18%11.5011.5111108989090
  2.17%11.51.410.156188.28889.490
  3.08%10.7010.744087.387.3090
  1.21%10.7-0.110.8910188.888.888.790
  4.09%10.6010.633086.586.5090

券商虧損排行 - 2024/04/16 ~ 2024/04/30

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  -1.25%-358.4154.5-512.9-2349532987.486.287.890
  -1.76%-226.2-44.8-181.4-687914787.587.987.390
  -1.78%-100-39.3-60.7-22426487.688.287.290
  -3.00%-96.8-1-95.8-3423787.387.887.390
  -3.37%-64.4-2.5-62-202228788.186.990
  -3.49%-57.7-6.7-51-1631987.18986.890
  -1.43%-55.62.5-58.1-4044488.587.988.590
  -1.32%-54.63.6-58.2-33134788.28888.390
  -3.28%-45.70-45.7-1601687.1087.190
  -4.94%-42.40-42.4-1001085.8085.890
  -3.72%-420-42-1301386.8086.890
  -1.90%-41.63.9-45.5-2142587.786.987.890
  -3.23%-33.8-1.9-31.9-1111287.28987.190
  -1.59%-26.62.9-29.5-1721988.186.888.390
  -4.05%-24.50-24.5-70786.5086.590
  -2.69%-23.60-23.6-1001087.6087.690
  -1.56%-23.4-0.8-22.5-1151788.288.388.190
  -4.35%-22.50-22.5-50686.386.586.390
  -2.53%-22.1-0.7-21.4-821087.487.787.390
  -3.12%-21.8-1.5-20.3-61887.388.687.190
  -3.13%-21.7-1.1-20.6-62886.787.186.690
  -3.01%-20.91-21.9-71886.885.986.990
  -1.15%-20.2-0.3-19.9-8112087.887.887.890
  -1.91%-20.2-8.6-11.5-471288.188.987.790
  -3.87%-20.10-20.1-50686.686.486.790
  -1.19%-19.9-2-17.9-9101988.188.28890
  -2.03%-17.90-17.9-901088.286.588.290
  -2.13%-16.90-16.9-90988.1088.190
  -0.35%-15.1-42.527.416493387.888.38790
  -1.10%-14.52-16.5-961588.187.888.290
  -1.94%-13.7-0.6-13.1-71888.288.788.190
  -3.14%-13.7-1.8-11.9-41587.388.88790
  -1.50%-13.30.2-13.5-911088.588.388.590
  -2.99%-13-5.9-7.2-13587.288.486.490
  -1.12%-130-13-130138908990
  -1.56%-12.31.6-13.9-63987.587.187.790
  -0.49%-12.2-23.711.57282088.188.687.490
  -3.48%-12.10-12.1-3048788.98790
  -4.65%-120-12-2038687.48690
  -2.72%-11.90-11.9-50587.6087.690
  -4.41%-11.40-11.4-30386.2086.290
  -4.25%-110-11-30386.3086.390
  -1.78%-110-11-70788.4088.490
  -2.46%-10.80-10.8-50587.8087.890
  -3.93%-10.20-10.2-30386.6086.690
  -1.58%-9.80-9.8-70788.6088.690
  -2.14%-9.4-0.6-8.8-41587.988.487.890
  -2.56%-90-9-30487.786.587.890
  -2.53%-8.9-1.5-7.4-31487.88987.590
  -1.93%-8.50-8.5-50588.3088.390
水星生醫*攜手旭富製藥 簽訂MTA開發抗癲癇藥物Anue鉅亨-2024/04/15
旭富新產能到位本季營運看增 觀音新廠產能再增5成Anue鉅亨-2023/10/03
星國阿茲海默三期順利解盲 旭富獨供原料藥營運吞補丸Anue鉅亨-2022/11/23
旭富 相關文章